Gui-Mei Kong1, Wen-Hua Tao1, Ya-Li Diao1, Peng-Hua Fang1, Ji-Jun Wang1, Ping Bo1, Feng Qian1. 1. Gui-Mei Kong, Wen-Hua Tao, Peng-Hua Fang, Ji-Jun Wang, Ping Bo, Feng Qian, Department of Jiangsu Key Laboratory of Integrated Traditional Chinese and Western Medicine for Prevention and Treatment of Senile Diseases, Jiangsu Co-innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses, Medical School of Yangzhou University, Yangzhou 225001, Jiangsu Province, China.
Abstract
AIM: To investigate the apoptotic effects of melittin on SGC-7901 cells via activation of the mitochondrial signaling pathway in vitro. METHODS: SGC-7901 cells were stimulated by melittin, and its effect on proliferation and apoptosis of was investigated by methyl thiazolyl tetrazolium assay, morphologic structure with transmission electron microscopy, annexin-V/propidium iodide double-staining assay, measuring mitochondrial membrane potential (MMP) levels, and analyzing reactive oxygen species (ROS) concentrations were analyzed by flow cytometry. Cytochrome C (Cyt C), apoptosis-inducing factor (AIF), endonuclease G (Endo G), second mitochondria-derived activator of caspases (Smac)/direct IAP binding protein with low isoelectric point (Diablo), and FAS were analyzed by western blot. The expression of caspase-3 and caspase-8 was measured using activity assay kits. RESULTS: Melittin was incubated at 1.0, 2.0, 4.0, or 6.0 μg/mL for 1, 2, 4, 6, or 8 h and showed a time- and concentration-dependent inhibition of SGC-7901 cell growth. Melittin induced SGC-7901 cell apoptosis, which was confirmed by typical morphological changes. Treatment with 4 μg/mL melittin induced early apoptosis of SGC-7901 cells, and the early apoptosis rates were 39.97% ± 3.19%, 59.27% ± 3.94%, and 71.50% ± 2.87% vs 32.63% ± 2.75% for 1, 2, and 4 h vs 0 h (n = 3, P < 0.05); the ROS levels were 616.53% ± 79.78%, 974.81% ± 102.40%, and 1330.94% ± 93.09% vs 603.74% ± 71.99% (n = 3, P < 0.05); the MMP values were 2.07 ± 0.05, 1.78 ± 0.29, and 1.16 ± 0.25 vs 2.55 ± 0.42 (n = 3, P < 0.05); caspase-3 activity was significantly higher compared to the control (5492.3 ± 321.1, 6562.0 ± 381.3, and 8695.7 ± 449.1 vs 2330.0 ± 121.9), but the caspase activity of the non-tumor cell line L-O2 was not different from that of the control. With the addition of the caspase-3 inhibitor (Ac-DEVD-CHO), caspase-3 activity was significantly decreased compared to the control group (1067.0 ± 132.5 U/g vs 8695.7 ± 449.1 U/g). The expression of the Cyt C, Endo G, and AIF proteins in SGC-7901 cells was significantly higher than those in the control (P < 0.05), while the expression of the Smac/Diablo protein was significantly lower than the control group after melittin exposure (P < 0.01). Ac-DEVD-CHO did not, however, have any effect on the expression of caspase-8 and FAS in the SGC-7901 cells. CONCLUSION: Melittin can induce apoptosis of human gastric cancer (GC) cells through the mitochondria pathways, and it may be a potent agent in the treatment of human GC.
AIM: To investigate the apoptotic effects of melittin on SGC-7901 cells via activation of the mitochondrial signaling pathway in vitro. METHODS: SGC-7901 cells were stimulated by melittin, and its effect on proliferation and apoptosis of was investigated by methyl thiazolyl tetrazolium assay, morphologic structure with transmission electron microscopy, annexin-V/propidium iodide double-staining assay, measuring mitochondrial membrane potential (MMP) levels, and analyzing reactive oxygen species (ROS) concentrations were analyzed by flow cytometry. Cytochrome C (Cyt C), apoptosis-inducing factor (AIF), endonuclease G (Endo G), second mitochondria-derived activator of caspases (Smac)/direct IAP binding protein with low isoelectric point (Diablo), and FAS were analyzed by western blot. The expression of caspase-3 and caspase-8 was measured using activity assay kits. RESULTS: Melittin was incubated at 1.0, 2.0, 4.0, or 6.0 μg/mL for 1, 2, 4, 6, or 8 h and showed a time- and concentration-dependent inhibition of SGC-7901 cell growth. Melittin induced SGC-7901 cell apoptosis, which was confirmed by typical morphological changes. Treatment with 4 μg/mL melittin induced early apoptosis of SGC-7901 cells, and the early apoptosis rates were 39.97% ± 3.19%, 59.27% ± 3.94%, and 71.50% ± 2.87% vs 32.63% ± 2.75% for 1, 2, and 4 h vs 0 h (n = 3, P < 0.05); the ROS levels were 616.53% ± 79.78%, 974.81% ± 102.40%, and 1330.94% ± 93.09% vs 603.74% ± 71.99% (n = 3, P < 0.05); the MMP values were 2.07 ± 0.05, 1.78 ± 0.29, and 1.16 ± 0.25 vs 2.55 ± 0.42 (n = 3, P < 0.05); caspase-3 activity was significantly higher compared to the control (5492.3 ± 321.1, 6562.0 ± 381.3, and 8695.7 ± 449.1 vs 2330.0 ± 121.9), but the caspase activity of the non-tumor cell line L-O2 was not different from that of the control. With the addition of the caspase-3 inhibitor (Ac-DEVD-CHO), caspase-3 activity was significantly decreased compared to the control group (1067.0 ± 132.5 U/g vs 8695.7 ± 449.1 U/g). The expression of the Cyt C, Endo G, and AIF proteins in SGC-7901 cells was significantly higher than those in the control (P < 0.05), while the expression of the Smac/Diablo protein was significantly lower than the control group after melittin exposure (P < 0.01). Ac-DEVD-CHO did not, however, have any effect on the expression of caspase-8 and FAS in the SGC-7901 cells. CONCLUSION: Melittin can induce apoptosis of humangastric cancer (GC) cells through the mitochondria pathways, and it may be a potent agent in the treatment of human GC.
Authors: Dong Ju Son; Seong Jong Ha; Ho Sueb Song; Yong Lim; Yeo Pyo Yun; Jae Woong Lee; Dong Cheul Moon; Young Hyun Park; Byeoung Soo Park; Min Jong Song; Jin Tae Hong Journal: J Pharmacol Exp Ther Date: 2006-01-09 Impact factor: 4.030
Authors: Andreas Ioannis Karsisiotis; Oliver M Deacon; Badri S Rajagopal; Colin Macdonald; Tharin M A Blumenschein; Geoffrey R Moore; Jonathan A R Worrall Journal: Biomol NMR Assign Date: 2015-06-30 Impact factor: 0.746
Authors: Mi Hee Park; Myoung Suk Choi; Dong Hoon Kwak; Ki-Wan Oh; Do Young Yoon; Sang Bae Han; Ho Sueb Song; Min Jong Song; Jin Tae Hong Journal: Prostate Date: 2010-11-17 Impact factor: 4.104
Authors: Enrique Barrajón-Catalán; María P Menéndez-Gutiérrez; Alberto Falco; Alfredo Carrato; Miguel Saceda; Vicente Micol Journal: Cancer Lett Date: 2009-11-05 Impact factor: 8.679
Authors: Stephanie Lamart; Rebecca Imran; Steven L Simon; Kazutaka Doi; Lindsay M Morton; Rochelle E Curtis; Choonik Lee; Vladimir Drozdovitch; Roberto Maass-Moreno; Clara C Chen; Millie Whatley; Donald L Miller; Karel Pacak; Choonsik Lee Journal: Phys Med Biol Date: 2013-12-04 Impact factor: 3.609
Authors: Shantanu Guha; Ryan P Ferrie; Jenisha Ghimire; Cristina R Ventura; Eric Wu; Leisheng Sun; Sarah Y Kim; Gregory R Wiedman; Kalina Hristova; Wimley C Wimley Journal: Biochem Pharmacol Date: 2021-09-17 Impact factor: 6.100
Authors: Usama A Fahmy; Shaimaa M Badr-Eldin; Hibah M Aldawsari; Nabil A Alhakamy; Osama A A Ahmed; Mohamed F Radwan; Basma G Eid; Shaban R M Sayed; Gamal A El Sherbiny; Walaa Abualsunun Journal: Drug Deliv Date: 2022-12 Impact factor: 6.819